Trevi Therapeutics Inc (TRVI)
11.36
+0.71%
Trevi Therapeutics Inc (TRVI) is currently trading at $11.36. This represents a gain of 0.71% from the previous session. With a market capitalization of $1.46B, TRVI is a key component of the Health Care sector. Investors looking to trade TRVI should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade TRVI commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Trevi Therapeutics Inc (TRVI) shows a bullish trend. Analysts are watching the 11.74 level closely.
Fundamentals
Mkt Cap1.46B
P/E Ratio0.0000
Volume0
60-Day Technical Chart
Advanced Charting
Need more indicators for TRVI? Use the world's #1 platform.
Open TRVI on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $11
| Metric |
TRVI +0.71% |
HONE -1.79% |
AVO -0.52% |
BBOT +0.17% |
|---|---|---|---|---|
| Price | $11.36 | $12.10 | $11.46 | $11.96 |
| Mkt Cap | $1.46B | $26.07B | $0.81B | $0.96B |
| - | View → | View → | View → |
Latest Headlines
Does Trevi Therapeutics (TRVI) Have the Potential to Rally 102.07% as Wall Street Analysts Expect?
Finviz • Feb 23, 2026
Long Term Trading Analysis for (TRVI) (TRVI:CA)
Stock Traders Daily • Feb 25, 2026
Haduvio Opportunity Positions Trevi (TRVI) for Multibagger Gains, Says Morgan Stanley
Yahoo Finance • Sep 11, 2025
Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer
PR Newswire • Dec 4, 2025
Trevi Therapeutics to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference
GlobeNewswire • Feb 17, 2026
● Gemini Agentic AI Analyst Insight for TRVI
Market Education
- Fails to Deliver DeMystified May 31, 2024
- 🔥 Top 7 AI Penny Stocks That Could Explode in 2025 Nov 16, 2025
- Large Cap at Lowest Price Apr 9, 2024
External Research